| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Regulus Therapeutics Inc. | Sr. VP & General Counsel | Common Stock | 10.1K | $12K | $1.19 | Jan 18, 2024 | Direct |
| Regulus Therapeutics Inc. | Sr. VP & General Counsel | Stock Option (Right to Buy) | 363K | May 20, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RGLS | Regulus Therapeutics Inc. | May 20, 2024 | 1 | $0 | 4 | May 21, 2024 | Sr. VP & General Counsel |
| RGLS | Regulus Therapeutics Inc. | Jan 18, 2024 | 1 | -$6.51K | 4 | Jan 18, 2024 | Sr. VP & General Counsel |
| RGLS | Regulus Therapeutics Inc. | Jan 12, 2024 | 2 | $0 | 4 | Jan 17, 2024 | Sr. VP & General Counsel |
| RGLS | Regulus Therapeutics Inc. | Aug 10, 2023 | 1 | $0 | 4 | Aug 14, 2023 | Sr. VP & General Counsel |
| RGLS | Regulus Therapeutics Inc. | Jan 11, 2023 | 1 | $0 | 4/A | Jan 17, 2023 | Sr. VP & General Counsel |
| RGLS | Regulus Therapeutics Inc. | May 10, 2022 | 1 | $0 | 4 | May 11, 2022 | Sr. VP & General Counsel |
| RGLS | Regulus Therapeutics Inc. | Jan 12, 2022 | 1 | $0 | 4 | Jan 26, 2022 | Sr. VP & General Counsel |
| RGLS | Regulus Therapeutics Inc. | May 17, 2021 | 1 | -$765 | 4 | May 17, 2021 | Sr. VP & General Counsel |